Alpine Associates Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Alpine Associates Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,322,400	Closed	-$41.8M	–	37
2020 Q2	$41.8M	Buy	+2,322,400	New	+$32.3M	2.4%	16

Alpine Associates Management's PTLA Position: Q3 2020 in Review

Alpine Associates Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 2,322,400 shares — an estimated $41.8M sold.

Alpine Associates Management first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $41.8M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Alpine Associates Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Alpine Associates Management sold 2,322,400 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $41.8M.
Alpine Associates Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
Alpine Associates Management's Portola Pharmaceuticals, Inc. position peaked at $41.8M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Alpine Associates Management's 13F filing for Q3 2020, filed 10 Nov 2020.